Drug Topics
SEPTEMBER 13, 2022
Several provisions in the law are designed to protect and foster the biosimilar market. But some representatives of the sector see CMS drug price negotiation as a threat to profit margins.
STAT
SEPTEMBER 13, 2022
Akero Therapeutics said Tuesday that an experimental medicine improved liver scarring at twice the rate of a placebo without worsening other symptoms — achieving the main goal of a mid-stage clinical trial involving patients with the fatty liver disease known as NASH. If the encouraging study results are confirmed in later Phase 3 clinical trials, the Akero drug, called efruxifermin, could become an effective treatment for a chronic disease that has grown into one of the leading causes of
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 13, 2022
CBD can be used to treat a myriad of women’s health conditions, but research is still limited.
Pharmaceutical Technology
SEPTEMBER 13, 2022
Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). Under the deal, Microsoft's computational services, Cloud and artificial intelligence (AI) will be merged with the drug discovery, development and data science expertise of Novo Nordisk.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
SEPTEMBER 13, 2022
New research adds further evidence that early in life antibiotic exposure can have lifelong impact.
Pharmacy Times
SEPTEMBER 13, 2022
The New Drug Application for aripiprazole 2-month, ready-to-use, long-acting injectable could lead to the first FDA approval of a 2-month schizophrenia and bipolar I disorder antipsychotic treatment.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
SEPTEMBER 13, 2022
It is currently indicated for the treatment of adult patients with active psoriatic arthritis and adult patients with oral ulcers associated with Behçet's Disease.
Drug Store News
SEPTEMBER 13, 2022
Ulta Beauty has revealed the names of the eight early-stage BIPOC beauty brands that will participate in its inaugural Muse Accelerator program.
Pharmacy Times
SEPTEMBER 13, 2022
Prescribers signed a letter expressing concerns about recommendations for restrictions on compounded hormones, which millions of women and other patient populations rely on.
STAT
SEPTEMBER 13, 2022
The first case of polio in the U.S. in a decade has triggered intense debate and unease. On Friday, New York Gov. Kathy Hochul declared a disaster after polio virus was detected in the wastewater of a third county in the state. Health officials are advocating for improving domestic vaccination rates to prevent a resurgence of polio, as they should. But this is only part of the solution.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
SEPTEMBER 13, 2022
Convenient care clinics continue to expand their offerings and their appeal to consumers.
STAT
SEPTEMBER 13, 2022
The best time to buy a car is at model year-end sales, and Black Friday deals can’t be beat for major appliances. Ever wonder why you don’t see a President’s Day sale on colonoscopies? Or ads for buy-one-get-one free knee replacements? In most instances, offering patients a discount on health care services would be considered an improper patient inducement under the federal Civil Monetary Penalties Law and the Anti-Kickback Statute.
Drug Store News
SEPTEMBER 13, 2022
The guide details how to create or improve workplace practices that uplift workers, ensure they are heard and establish a culture of well-being.
ISPE
SEPTEMBER 13, 2022
Survey: How Does Your Company Dispose of Single-Use Assemblies? Trudy Patterson. Tue, 09/13/2022 - 11:40. iSpeak Blog. iSpeak. Survey: How Does Your Company Dispose of Single-Use Assemblies? Cristina Van Loy. 13 September 2022. Single-use plastics are critical for healthcare, life sciences laboratories, and bioprocessing. They have many benefits over other materials and their use is increasing.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
DiversifyRx
SEPTEMBER 13, 2022
Chick-Fil-A (CFA) doesn’t make many mistakes. However, I noticed a big marketing mistake after a recent trip, and I see pharmacies make it all the time too. Butchering A Good Strategy. Knowing a strategy and implementing it incorrectly is the same as not knowing at all. Proper implementation is the key to success. Mistakes made when taking action are often why strategies fail.
STAT
SEPTEMBER 13, 2022
Hello, everyone, and how are you today? The skies over the Pharmalot campus remain gloomy this morning, but our spirits are sunny, nonetheless. After all, as the Morning Mayor liked to say: Every new day should be unwrapped like a precious gift. So while you tug on the ribbon, we will get busy gathering interesting items for you to peruse. So time to get started.
Drug Topics
SEPTEMBER 13, 2022
Influenza vaccine administration timing and considerations for senior patients are explored by key opinion leaders.
STAT
SEPTEMBER 13, 2022
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Drug Store News
SEPTEMBER 13, 2022
Lemme, which features science-backed formulas, is releasing three gummy supplements that tackle a variety of needs.
PioneerRx
SEPTEMBER 13, 2022
As we all know, social media has become more than an outlet to post pictures of your food or your cat’s latest destructive antics. It has long been a platform to.
Drug Topics
SEPTEMBER 13, 2022
The panel discusses vaccination for senior patient populations, citing the most recent ACIP recommendations.
PharmaVoice
SEPTEMBER 13, 2022
COVID-19 has inspired renewed urgency in the need for weapons to combat antimicrobial resistant infections and new hope of government funding to meet the challenge.
Drug Store News
SEPTEMBER 13, 2022
Hostess Bouncers are bite-sized snack cakes available in flavors inspired by Twinkies, Ding Dongs and Donettes.
PharmExec
SEPTEMBER 13, 2022
Indu Navar, founder of Everything ALS, speaks with Pharm Exec about how she lost her husband to the disease and how she's trying to improve the way its diagnosed.
Drug Store News
SEPTEMBER 13, 2022
The parties will work toward ensuring access to drugs at affordable prices to patients in need.
Outsourcing Pharma
SEPTEMBER 13, 2022
Bayer Pharma has enlisted Clariness to support its new study review process by providing pre-clinical trial patient insights and post-trial feedback.
Drug Store News
SEPTEMBER 13, 2022
After Sept. 18, the SCAN app will no longer be available at Wegmans, the company said.
pharmaphorum
SEPTEMBER 13, 2022
It’s all change at Alphabet’s life sciences business Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman, who will have to decide how to spend the new money. Verily’s Andrew Conrad. Company founder Andy Conrad is stepping down as CEO and moving to the executive chairman position, while current president Stephen Gillett is being promoted to the CEO role two years after joining the company from Go
European Pharmaceutical Review
SEPTEMBER 13, 2022
Researchers suggest an investigational combination therapy could offer a new therapeutic option for Merkel cell carcinoma patients who may not respond to the current standard of care. Merkel cell carcinoma is a rare but aggressive form of skin cancer that has a high rate of metastasis and poor patient outcomes. The current standard of care for patients with recurrent, unresectable or metastatic disease is immune checkpoint inhibitor monotherapy targeting anti-programmed death receptor 1 (anti-PD
Pharmacy Times
SEPTEMBER 13, 2022
An estimated 31.4% of individuals with non-squamous non–small cell lung cancer treated with the combination were alive at 3 years compared to 17.3% for those on chemotherapy alone.
Pharmaceutical Technology
SEPTEMBER 13, 2022
The advent of immune checkpoint inhibition has arguably been the greatest breakthrough for the treatment of metastatic solid tumours, with durable complete responses observed across multiple cancer types. With success in the metastatic setting, pharma companies, researchers and physicians have invested heavily in exploring the use of immune checkpoint inhibitors (ICIs) for the treatment of locally advanced disease, hoping to increase response rates and prevent disease progression.
Pharmacy Times
SEPTEMBER 13, 2022
Ribociclib with endocrine therapy was found to increase the median overall survival of patients with HR+/HER2- advanced breast cancer with visceral metastases to nearly 5 years.
Drug Store News
SEPTEMBER 13, 2022
Balser also has been named to the board’s medical affairs committee.
Pharmacy Times
SEPTEMBER 13, 2022
Trastuzumab deruxtecan produces a confirmed objective response rate of 53.8% and 42.9% in the 5.4 mg/kg arm and 6.4 mg/kg treatment arms, respectively, among patients with HER2 mutant non-small cell lung cancer.
Expert insights. Personalized for you.
200 
Let's personalize your content